No Detail Found!

An in vitro antimicrobial activity of Beauveria bassiana secondary metabolites

Author(s)
Adil Aksoy Eskil Vocational High School, Laboratory Veterinary Science, Aksaray University, Aksaray, Turkey
Saif M. Dmour Department of Medical Analysis, Princess Aisha Bent Al-Hussein College of Nursing and Health Sciences, Al Hussein bin Talal University, Jordan
Haitham Qaralleh Department of Medical Laboratory Sciences, Faculty of Science, Mutah University, Mutah, Karak, 61710, Jordan,
Waleed S. Alwaneen Advanced Agriculture & Food Technologies Institute, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia
Reem M. Farsi Department of Biological Sciences, Facultyof Science, King Abdulaziz University, Jeddah, Saudi Arabia
Roaa M. Alreemi Department of Biochemistry, College of Science, University of Jeddah,Jeddah, Saudi Arabia
Mahmoud W. El Hindi Department of Biotechnology, Faculty of Science, Islamic University of Gaza, Gaza, Palestine
Farida N. Mosleh Department of Biotechnology, Faculty of Science, Islamic University of Gaza, Gaza, Palestine
Sabreen El Mazloom Department of Biotechnology, Faculty of Science, Islamic University of Gaza, Gaza, Palestine
Dalia Sukmawati Department of Biology, Faculty of Mathematics and Natural Science,Universitas Negeri Jakarta, Jakarta,Indonesia
Almira M. Priskaningrum Department of Biology, Faculty of Mathematics and Natural Science, Universitas Negeri Jakarta, Jakarta, Indonesia
Abstract
Fungi are organisms that provide various environmental services. Beauveria (B.) bassiana (Order: Hypocreales, Family: Cordycipitaceae) is an example of an entomopathogenic fungus developed and used for many agricultural, biomedical, and medicinal purposes. A crude extract of B. bassiana was made using a culture broth to test its antimicrobial effects against several animal pathogenic bacteria, comprising Klebsiella (K.) pneumoniae, Escherichia (E.) coli, and Staphylococcus (S.) aureus and fungi (Candida (C.) albicans). In 250 mL Erlenmeyer flasks, a liquid median (100 ml) was infected with 1 ml of an aqueous conidial suspension (107 conidia/ml). The flasks were incubated at 27.2°C on a rotary shaker (180 rpm) for seven days. The fermented broth was filtered to remove the biomass and obtain a crude extract of B. bassiana at various concentrations, which was later used for the disk diffusion method. Results demonstrated that the crude extracts effectively against the tested microorganisms and fungi. The B. bassiana extract showed an effect against K. pneumoniae, C. albicans, S. aureus, and E. coli with inhibition zones measuring 22, 23, 25, and 27 mm in diameter, respectively. The regression analysis indicated that each concentrate increase in B. bassiana culture filtrate showed a significant increase in the inhibition zone by 0.2342, 0.2330, 0.1909, and 0.2010 mm for the groups of S. aureus, E. coli, K. pneumoniae, and C. albicans, respectively. The amplification of the BbbsIS gene produced a single fragment of an approximate length of 156-190 bp. This study confirmed that the antimicrobial drug could be produced from B. bassiana extracts to prevent many diseases associated with microbial and fungal infections. It also developed an approach constructed by absolute PCR quantification for the expression of genes encoding the synthetase enzymes of the secondary metabolites viz., bassianolide (BbbslS), beauvericin (BbbeaS), and B-tubulin during the initial times of contagion.
Publication Details
Page(s) 331-336
Published Journal: Pakistan Journal of Agricultural Sciences, Volume: 60, Issue: 3, Year: 2023

Request the full text from PASTIC

Keywords
Escherichia coli, secondary metabolites, antimicrobial activity, Klebsiella pneumoniae, Beauveria bassiana, Staphylococcus Aureus.
0

Citations

0

Downloads

71

Views